Abstract:OBJECTIVE: To explore the different clinical and CT features distinguishing COVID-19 from H1N1 influenza pneumonia. PATIENTS AND METHODS: We compared two independent cohorts of COVID-19 pneumonia (n=405) and H1N1 influenza pneumonia (n=78), retrospectively. All patients were confirmed by RT-PCR. Four hundred and five cases of COVID-19 pneumonia were confirmed in nine hospitals of Zhejiang province, China from January 21 to February 20, 2020. Seventy-eight cases of H1N1 influenza pneumonia were confirmed in our hospital from January 1, 2017 to February 29, 2020. Their clinical manifestations, laboratory test results, and CT imaging characteristics were compared. RESULTS: COVID-19 pneumonia patients showed less proportions of underlying diseases, fever and respiratory symptoms than those of H1N1 pneumonia patients (p<0.01). White blood cell count, neutrophilic granulocyte percentage, C-reactive protein, procalcitonin, D-Dimer, and lactate dehydrogenase in H1N1 pneumonia patients were higher than those of COVID-19 pneumonia patients (p<0.05). H1N1 pneumonia was often symmetrically located in the dorsal part of inferior lung lobes, while COVID-19 pneumonia was unusually showed as a peripheral but non-specific lobe distribution. Ground glass opacity was more common in COVID-19 pneumonia and consolidation lesions were more common in H1N1 pneumonia (p<0.01). COVID-19 pneumonia lesions showed a relatively clear margin compared with H1N1 pneumonia. Crazy-paving pattern, thickening vessels, reversed halo sign and early fibrotic lesions were more common in COVID-19 pneumonia than H1N1 pneumonia (p<0.05). Pleural effusion in COVID-19 pneumonia was significantly less common than H1N1 pneumonia (p<0.01). CONCLUSIONS: Compared with H1N1 pneumonia in Zhejiang, China, the clinical manifestations of COVID-19 pneumonia were more concealed with less underlying diseases and slighter respiratory symptoms. The more common CT manifestations of COVID-19 pneumonia included ground glass opacity with a relatively clear margin, crazy-paving pattern, thickening vessels, reversed halo sign, and early fibrotic lesions, while the less common CT manifestations of COVID-19 pneumonia included consolidation and pleural effusion.

Roentgenography and CT appearance in patients with influenza A (H7N9) virus pneumonia

Radiological Features of Human Infection with Avian Influenza A H7N9 Virus: A Report of Three Cases

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus: Serial Chest Radiographic and CT Findings

Dynamic Assessment of Lung Injury by Ultrasound in a Case with H7N9 Influenza.

CT Findings of Influenza A H1N1

Chest X-ray and CT Findings of Early H7N9 Avian Influenza Cases

Comparison of the Clinical and CT Features Between COVID-19 and H1N1 Influenza Pneumonia Patients in Zhejiang, China

Clinical presentations and imaging features of a novel avian-origin influenza H7N9

Clinical and Imaging Features of Patients with Severe Influenza A (H1N1)

Preliminary imaging findings of novel reassortant avian-origin influenza A (H7N9) pneumonia

Imaging findings of severe and critical pulmonary infections with H1N1 and its correlation with clinical features

Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus.

Clinical findings in 111 cases of influenza A (H7N9) virus infection.

Influenza A virus: radiological and clinical findings of patients hospitalised for pandemic H1N1 influenza

Initial HRCT Findings of Novel Influenza A (H1N1) Infection

Clinical Features of Pneumonia Caused by 2009 Influenza A(H1N1) Virus in Beijing, China

Clinical and Temporal Radiological Findings from Critical Patients with COVID-19 Pneumonia: A Descriptive Study

Association of Radiologic Findings with Mortality in Patients with Avian Influenza H7N9 Pneumonia

Chest CT Imaging Characteristics and Their Evolution of 48 Patients with COVID-19 in Hengyang, China.

Clinical characteristics and CT findings of COVID-19

Comparative study of hematological and radiological feature of severe/critically ill patients with COVID‐19, influenza A H7N9, and H1N1 pneumonia